113.90
0.18 (0.16%)
| 前收盘价格 | 113.72 |
| 收盘价格 | 113.72 |
| 成交量 | 1,787,392 |
| 平均成交量 (3个月) | 808,531 |
| 市值 | 3,907,049,216 |
| 市盈率 (P/E TTM) | 23.39 |
| 预期市盈率 (P/E Forward) | 46.51 |
| 价格/销量 (P/S) | 7.77 |
| 股市价格/股市净资产 (P/B) | 8.48 |
| 52周波幅 | |
| 利润日期 | 7 May 2026 |
| 营业毛利率 | 10.03% |
| 营业利益率 (TTM) | 19.12% |
| 稀释每股收益 (EPS TTM) | 1.42 |
| 季度收入增长率 (YOY) | 48.20% |
| 季度盈利增长率 (YOY) | 110.60% |
| 总债务/股东权益 (D/E MRQ) | 194.67% |
| 流动比率 (MRQ) | 9.10 |
| 营业现金流 (OCF TTM) | 49.38 M |
| 杠杆自由现金流 (LFCF TTM) | -84.81 M |
| 资产报酬率 (ROA TTM) | 4.21% |
| 股东权益报酬率 (ROE TTM) | 22.99% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | TransMedics Group, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.0 |
| 平均 | 0.75 |
|
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.03% |
| 机构持股比例 | 121.56% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 175.00 (Oppenheimer, 53.64%) | 购买 |
| 中 | 165.00 (44.86%) | |
| 低 | 130.00 (Stifel, 14.14%) | 保留 |
| 平均值 | 159.67 (40.18%) | |
| 总计 | 4 购买, 2 保留 | |
| 平均价格@调整类型 | 132.34 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Stifel | 09 Mar 2026 | 130.00 (14.14%) | 保留 | 134.77 |
| Evercore ISI Group | 25 Feb 2026 | 170.00 (49.25%) | 购买 | 131.85 |
| JP Morgan | 25 Feb 2026 | 149.00 (30.82%) | 保留 | 131.85 |
| Needham | 25 Feb 2026 | 174.00 (52.77%) | 购买 | 131.85 |
| Oppenheimer | 25 Feb 2026 | 175.00 (53.64%) | 购买 | 131.85 |
| Piper Sandler | 25 Feb 2026 | 160.00 (40.47%) | 购买 | 131.85 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合